The long-term objective is to understand the role of recombination processes and DNA mismatch repair in the ability of cells to survive drug and radiation-induced DNA damage. We have obtained data with various agents with different mechanisms of action suggesting that DNA double-strand breaks are a common denominator in cells exposed to DNA damaging agents. These agents include not only those occurring naturally (nitric oxide), those used in the therapy of neoplastic disease (e.g., cisplatin, streptozotocin) but also genotoxicants in our environment (e.g.,methylating agents). Ionizing radiation is known to produce double-strand breaks directly but the other agents do not. We hypothesize that drug-induced double-strand breaks are formed by replication through DNA containing single-strand nicks produced by repair processes leading to collapse of the replication fork. Recombination mechanisms are required to repair these double-strand breaks and are therefore extremely important for cellular defenses against these agents in combination with other repair pathways and replication restart proteins. To test our hypothesis we propose to use E. coli as a model system as more is known about DNA replication, repair and recombination than any other organism. Furthermore, mutant strains affecting these processes are available only in this organism. DNA mismatch repair is known to sensitize human and E. coli cells to the toxic effects of cisplatin and methylating agents. Indeed tumor cells resistant to these agents have been isolated from patients and shown to be deficient in mismatch repair. We hypothesize that the role of mismatch repair in drug- resistance is because it no longer interferes with recombinational repair of drug-induced damage. The first specific aim will test the hypothesis that double-strand breaks are formed in chromosomal DNA after exposure to nitric oxide, methylating agents and cisplatin using gamma-radiation as the control. We will use physical methods to detect such breaks. In the second aim, a simple recombination assay will be used to monitor the level of double-strand breaks induced by the agents listed above and by gamma radiation. We will also determine the gene products required for drug-induced recombination.
The third aim will use a biochemical assay with purified proteins and substrates to test the hypothesis that mismatch repair interferes with recombination. If these experiments support our model, it will open up a new approach to combat tumor cells by targeting recombination proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM063790-04
Application #
6913527
Study Section
Radiation Study Section (RAD)
Program Officer
Portnoy, Matthew
Project Start
2002-07-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2007-06-30
Support Year
4
Fiscal Year
2005
Total Cost
$270,300
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Pharmacology
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Carone, Benjamin R; Xu, Tao; Murphy, Kenan C et al. (2014) High incidence of multiple antibiotic resistant cells in cultures of in enterohemorrhagic Escherichia coli O157:H7. Mutat Res 759:1-8
Marinus, M G; Løbner-Olesen, A (2014) DNA Methylation. EcoSal Plus 2014:
Marinus, M G (2012) DNA Mismatch Repair. EcoSal Plus 2012:
Marinus, Martin G (2010) DNA methylation and mutator genes in Escherichia coli K-12. Mutat Res 705:71-6
Marinus, Martin G; Casadesus, Josep (2009) Roles of DNA adenine methylation in host-pathogen interactions: mismatch repair, transcriptional regulation, and more. FEMS Microbiol Rev 33:488-503
Nowosielska, Anetta; Marinus, M G (2008) DNA mismatch repair-induced double-strand breaks. DNA Repair (Amst) 7:48-56
Lobner-Olesen, Anders; Slominska-Wojewodzka, Monika; Hansen, Flemming G et al. (2008) DnaC inactivation in Escherichia coli K-12 induces the SOS response and expression of nucleotide biosynthesis genes. PLoS One 3:e2984
Murphy, Kenan C; Ritchie, Jennifer M; Waldor, Matthew K et al. (2008) Dam methyltransferase is required for stable lysogeny of the Shiga toxin (Stx2)-encoding bacteriophage 933W of enterohemorrhagic Escherichia coli O157:H7. J Bacteriol 190:438-41
Campellone, Kenneth G; Roe, Andrew J; Lobner-Olesen, Anders et al. (2007) Increased adherence and actin pedestal formation by dam-deficient enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 63:1468-81
Broadbent, Sarah E; Balbontin, Roberto; Casadesus, Josep et al. (2007) YhdJ, a nonessential CcrM-like DNA methyltransferase of Escherichia coli and Salmonella enterica. J Bacteriol 189:4325-7

Showing the most recent 10 out of 25 publications